An Exploratory Immune‐Associated Prognostic Signature and AREG‐Associated Phenotypes in Oral Squamous Cell Carcinoma

Abstract

Oral squamous cell carcinoma (OSCC) remains a clinically heterogeneous malignancy with unsatisfactory long‐term outcomes, particularly in patients with advanced disease and treatment resistance. Conventional clinicopathologic parameters incompletely capture the biological diversity of OSCC and provide limited guidance for individualised therapeutic stratification.